A Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults

American Journal of Geriatric Psychiatry

Volumn 24, Issue 11, 2016, Pages 949-963

  Maree, Rachel D ^a   Marcum, Zachary A ^b   Saghafi, Ester ^a   Weiner, Debra K ^a,c   Karp, Jordan F ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; geriatrics; prescription drug abuse; primary care; substance abuse

Indexed keywords

BENZODIAZEPINE; MESOGLYCAN; OPIATE; BENZODIAZEPINE DERIVATIVE;

DRUG DEPENDENCE; DRUG MISUSE; ELECTRONIC MEDICAL RECORD; EMBASE; EVIDENCE BASED PRACTICE; HOSPITAL ADMISSION; HUMAN; MEDICAL EDUCATION; MEDLINE; PEER REVIEW; PERSONAL EXPERIENCE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PSYCINFO; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; AGED; OPIATE ADDICTION; PRESCRIPTION DRUG MISUSE; STATISTICS AND NUMERICAL DATA;

AGED; BENZODIAZEPINES; HUMANS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 84992200599     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2016.06.003     Document Type: Review

References (65)

1. 1 Schulden, J., Lopez, M., Compton, W., Clinical implications of drug abuse epidemiology. Psychiatr Clin North Am 35 (2012), 411–423.
2. 2 American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Association, Washington, DC.
3. 3 Gilson, A.M., Kreis, P.G., The burden of the nonmedical use of prescription opioid analgesics. Pain Med 10 (2009), S89–S100.
4. 4 Centers for Disease Control and Prevention, Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. Morb Mortal Wkly Rep 60 (2011), 1487–1492.
5. 5 Olfson, M., Wang, S., Iza, M., et al. National trends in the office-based prescription of schedule II opioids. J Clin Psychiatry 74 (2013), 932–939.
6. 6 Becker, W., Tobin, D., Feillin, D., Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates. Arch Intern Med 171 (2011), 1034–1035.
7. 7 West, N.A., Severtson, S.G., Green, J.L., et al. Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend 149 (2015), 117–121.
8. 8 Campanelli, C.M., American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc 60 (2012), 616–631.
9. 9 Ries, R.K., Fiellin, D.A., Miller, S.C., et al. American Society for Addiction Medicine Principles of Addiction Medicine. 5th ed., 2014, Lippincott, Williams and Wilkins, Philadelphia, PA.
10. 10 Mulsant, B.H., Pollock, B.G., Psychopharmacology. Thakur, M.E., Blazer, D.G., Steffens, D.C., (eds.) Clinical Manual of Geriatric Psychiatry, 1st ed., 2014, American Psychiatric Publishing, Washington, DC, 17–82.
11. 11 Gossop, M., Moos, R., Substance misuse among older adults: a neglected but treatable problem. Addiction 103 (2008), 347–348.
12. 12 Koechl, B., Unger, A., Fischer, G., Age-related aspects of addiction. Gerontology 58 (2012), 540–544.
13. 13 Luijendijk, H.J., Tiemeier, H., Hofman, A., et al. Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol 65 (2007), 593–599.
14. 14 Petrovic, M., Vandierendonck, A., Mariman, A., et al. Personality traits and socio-epidemiological status of hospitalised elderly benzodiazepine users. Int J Geriatr Psychiatry 17 (2002), 733–738.
15. 15 McInnes, E., Powell, J., Drug and alcohol referrals: are elderly substance abuse diagnoses and referrals being missed?. BMJ 308 (1994), 444–446.
16. 16 Reynolds, K., Pietrzak, R.H., El-Gabalawy, R., et al. Prevalence of psychiatric disorders in U. S. older adults: findings from a nationally representative survey. World Psychiatry 14 (2015), 74–81.
17. 17 Han, B., Gfroerer, J., Colliver, J., et al. Substance use disorder among older adults in the United States in 2020. Addiction 104 (2009), 88–96.
18. 18 Gfroerer, J., Penne, M., Pemberton, M., et al. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend 69 (2003), 127–135.
19. 19 Kirschner, N., Ginsburg, J., Sulmasy, L.S., et al. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med, 2014, 10.7326/M13-2209 Position paper.
20. 20 Center for Substance Abuse Treatment, Substance Abuse Among Older Adults. Treatment Improvement Protocol (TIP) Series 26, 1998, Substance Abuse and Mental Health Services Administration, U.S. Dept. of Health and Human Services, Rockville, MD, 1–252 DHHS publication no. SMA 98-3179.7.
21. 21 APA, Position statement on mental health & substance abuse and aging: three resolutions. 2004.
22. 22 Moher, D., Liberati, A., Tetzlaff, J., et al. Academia and clinic Annals of Internal Medicine preferred reporting items for systematic reviews and meta-analyses. Ann Intern Med 151 (2009), 264–269.
23. 23 Cepeda, M.S., Fife, D., Chow, W., et al. Opioid shopping behavior: how often, how soon, which drugs, and what payment method. J Clin Pharmacol 53 (2012), 112–117.
24. 24 Cepeda, M.S., Fife, D., Chow, W., et al. Assessing opioid shopping behaviour. Drug Saf 35 (2012), 325–334.
25. 25 Jena, A.B., Goldman, D., Weaver, L., et al. Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims. BMJ, 348, 2014, g1393.
26. 26 Alvarenga, J., de Layola Filho, A., Firmo, J., et al. A population based study on health conditions associated with the use of benzodiazepines among older adults (The Bambuí Health and Aging Study). Estudo de base populacional sobre condições de saúde associadas ao uso de benzodiazepínicos em idosos (Proje). Cad Saude Publica 25 (2009), 605–612.
27. 27 Voyer, P., Préville, M., Cohen, D., et al. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging 29 (2010), 205–213.
28. 28 Landreat, M.G., Vigneau, C.V., Hardouin, J.B., et al. Can we say that seniors are addicted to benzodiazepines?. Subst Use Misuse 45 (2010), 1988–1999.
29. 29 Centers for Disease Control and Prevention, Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. Morb Mortal Wkly Rep 59 (2010), 705–709.
30. 30 Centers for Disease Control and Prevention, Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999–2010. Morb Mortal Wkly Rep 62 (2013), 537–542.
31. 31 Mura, T., Tzourio, C., Chevassus, H., Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the three-city study. Eur Neuropsychopharmacol 23 (2013), 212–223.
32. 32 Carriere, I., Mura, T., Peres, K., et al. Elderly benzodiazepine users at increased risk of activity limitations: influence of chronicity, indications, and duration of action—the three-city cohort. Am J Geriatr Psychiatry 23 (2015), 840–851.
33. 33 Neutel, C.I., Skurtveit, S., Berg, C., et al. Multiple prescribers in older frequent opioid users—does it mean abuse?. J Popul Ther Clin Pharmacol 20 (2013), e397–e405.
34. 34 Blazer, D., Wu, L.-T., Non-prescription use of pain relievers among middle aged and elderly community adults: national survey on drug use and health. J Am Geriatr Soc 57 (2009), 1252–1257.
35. 35 Voyer, P., McCubbin, M., Cohen, D., et al. Unconventional indicators of drug dependence among elderly long-term users of benzodiazepines. Issues Ment Health Nurs 25 (2004), 603–628.
36. 36 Voyer, P., Roussel, M.E., Berbiche, D., et al. Effectively detect dependence on benzodiazepines among community-dwelling seniors by asking only two questions. J Psychiatr Ment Health Nurs 17 (2010), 328–334.
37. 37 Gugelmann, H., Shofer, F.S., Meisel, Z.F., et al. Multidisciplinary intervention decreases the use of opioid medication discharge packs from 2 urban EDs. Am J Emerg Med 31 (2013), 1343–1348.
38. 38 Wilsey, B.L., Fishman, S.M., Casamalhuapa, C., et al. Documenting and improving opioid treatment: the Prescription Opioid Documentation and Surveillance (PODS) System. Pain Med 10 (2009), 866–877.
39. 39 Rutkow, L., Turner, L., Lucas, E., et al. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Aff (Millwood) 34 (2015), 484–492.
40. 40 Islam, M., McRae, I.S., An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol, 15, 2014, 46.
41. 41 Cook, J., Biyanova, T., Thompson, R., et al. Older primary care patients’ willingness to consider discontinuation of chronic benzodiazepines. Gen Hosp Psychiatry 29 (2007), 396–401.
42. 42 Kan, C.C., Breteler, M.H., van der Ven, A.H., et al. Cross-validation of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Compr Psychiatry 42 (2001), 433–439.
43. 43 Cuevas, C., Sanz, E.J., Fuente, J., et al. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 95 (2000), 245–250.
44. 44 Kalapatapu, R.K., Sullivan, M.A., Prescription use disorders in older adults. Am J Addict 19 (2011), 515–522.
45. 45 Gorgels, W.J.M.J., Oude Voshaar, R.C., Mol, A.J.J., et al. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Fam Pract 23 (2006), 65–72.
46. 46 van de Steeg-van Gompel, C.H.P., Wensing, M., De Smet, P., et al. Implementation of a discontinuation letter to reduce long-term benzodiazepine use—a cluster randomized trial. Drug Alcohol Depend 99 (2009), 105–114.
47. 47 Mol, J.J., Oude Voshaar, R.C., Gorgels, W.J.M.J., et al. The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial. Addict Behav 31 (2006), 211–222.
48. 48 Salonoja, M.A., Salminen, M.A., Aarnio, P.E., et al. One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing 39 (2010), 313–319.
49. 49 Gould, R.L., Coulson, M.C., Patel, N., et al. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry 204 (2014), 98–107.
50. 50 Alassaad, A., Bertilsson, M., Gillespie, U., et al. The effects of pharmacist intervention on emergency department visits in patients 80 years and older: subgroup analyses by number of prescribed drugs and appropriate prescribing. PLoS ONE, 9, 2014, e111797.
51. 51 Kuerbis, A., Sacco, P., A review of existing treatments for substance abuse among the elderly and recommendations for future directions. Subst Abuse 7 (2013), 13–37.
52. 52 Schonfeld, L., King-Kallimanis, B.L., Duchene, D.M., et al. Screening and brief intervention for substance misuse among older adults: the Florida BRITE project. Am J Public Health 100 (2010), 108–114.
53. 53 Ayalon, L., Jin, C., McCulloch, C.E., et al. Integrated specialty mental health care among older minorities improves access but not outcomes: results of the PRISMe study. Int J Geriatr Psychiatry 23 (2008), 1086–1092.
54. 54 Eden, J., Maslow, K., Le, M., et al. The Mental Health and Substance Use workforce for Older Adults: In Whose Hands?. 2012, National Academies Press, Washington, DC.
55. 55 Buck, J.A., The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff (Millwood) 30 (2011), 1402–1410.
56. 56 Pating, D.R., Miller, M.M., Goplerud, E., et al. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatr Clin North Am 35 (2012), 327–356.
57. 57 Baldoni, A.D.O., Ayres, L.R., Martinez, E.Z., et al. Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012. Int J Clin Pharm 36 (2014), 316–324.
58. 58 Bashir, K., King, M., Ashworth, M., Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract 44 (1994), 408–412.
59. 59 Bradley, M.C., Fahey, T., Cahir, C., et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 68 (2012), 1425–1433.
60. 60 Brown, J., Setnik, B., Lee, K., et al. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag 7 (2011), 467–483.
61. 61 Cook, J.M., Biyanova, T., Masci, C., et al. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med 22 (2007), 1094–1100.
62. 62 Huang, A.R., Mallet, L., Prescribing opioids in older people. Maturitas 74 (2013), 123–129.
63. 63 Kuerbis, A., Sacco, P., Blazer, D.G., et al. Substance abuse among older adults. Clin Geriatr Med 30 (2014), 629–654.
64. 64 Lanier, W.A., Johnson, E.M., Rolfs, R.T., et al. Risk factors for prescription opioid-related death, Utah, 2008–2009. Pain Med 13 (2012), 1580–1589.
65. 65 Beaudoin, F.L., Merchant, R.C., Clark, M.A., Prevalence and detection of prescription opioid misuse and prescription opioid use disorder among emergency department patients 50 years of age and older: performance of the Prescription Drug Use Questionnaire, Patient Version. Am J Geriatr Psychiatry, 2016, 10.1016/j.jagp.2016.03.010 in press.